PL EN


Preferences help
enabled [disable] Abstract
Number of results
2011 | 30 | 85-97
Article title

Application of Platelet Rich Plasma in Sports Medicine

Content
Title variants
Languages of publication
EN
Abstracts
EN
Any new method of treatment is associated with high expectations for its success, particularly if the therapy is based not only on the premise of achieving a symptomatic effect, but also improving functional quality and repairing structurally damaged tissues. Platelet Rich Plasma (PRP) application was shown to be a successful catalyst in the healing process for a wide variety of conditions in animal and human models. However, its use has been controversial due to many types of the PRP definition, optimal concentration, and modalities of implementation. In the qualification of patients for PRP treatment, not only should medical indications be considered, but also the role of participation in therapy with a physiotherapist supervising physical parameters and techniques used during recovery time. Further study is required in order to define optimal handling procedures of PRP injection. Long-term follow up will reveal if the promise of this substance can be realized and implemented to maximize its potential as a therapeutic remedy.
Publisher

Year
Volume
30
Pages
85-97
Physical description
Dates
published
1 - 12 - 2011
online
25 - 12 - 2011
Contributors
  • Galen Orthopaedics, Bieruń, Poland
  • Department of Physiological, Medical Science Academy of Physical Education, Katowice, Poland
author
  • Galen Orthopaedics, Bieruń, Poland
  • Department of Physical Culture and Health Promotion, University of Szczecin, Poland
References
  • Ackermann PW, Ahmed M, Kreicbergs A. Early nerve regeneration after Achilles tendon rupture - a prerequisite for healing? J Orthop Res, 2002 Jul; 20(4): 849-856.[Crossref][PubMed]
  • Alfredson H, Ohberg L, Forsgren S. Is vasculo- neural ingrowth the cause of pain in chronic Achilles tendinosis. An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnosic injections. Knee Surg Sports Traumatol Arthrosc, 2003 Sep; 11(5): 334-8.[Crossref]
  • Alfredson H. The chronic painful Achilles and patellar tendon: research on basic biology and treatment. Scand J Med Sci Sports, 2005 Aug; 15(4): 252-9.[PubMed][Crossref]
  • Almdahl SM, Veel T, Halvorsen P, Vold MB, Molstad Pl. Randomized prospective trial of saphenous vein harvest site infection after wound closure with and without topical application of autologous platelet-rich plasma. Eur J Cardiothorac Surg, 2011 Jan; 39(1): 44-48.[Crossref][WoS][PubMed]
  • Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost, 2004 Jan; 91: 4-15.[PubMed]
  • Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enrich with growth factors and other active substances. J Bone Joint Surg Br, 2007 Mar; 89(3): 417-20.[Crossref][WoS]
  • Casabona F, Priano V, Vallerino V, Cogliandro A, Lavagnino G. New Surgical Approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration. Plastic Reconstr Surg., 2010 Oct; 126(4): 210e-211e.
  • Chen TM, Tsai JC, Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extermity ulcers. Dermatol Surg, 2010 Apr; 36(4): 453-60.[WoS][Crossref]
  • Chomicki-Bindas P, Zakrzewski P, Pomianowski S. Platelets rich plasma with growth factors as a novel promissing technique in the bone and soft tissue healing in orthopaedics. Advances in Medical Sciences, 2010; 2: 153-157.
  • Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med, 2011 Sep; 45(12): 966-71.[PubMed][WoS][Crossref]
  • Davis JJ, Mason KT, Clark DA. Achilles tendon ruptures stratified by age, race, and cause of injury among active duty U. S. Military members. Mil Med, 1999; 164(12): 872-3.[PubMed]
  • Dohan Ehrenfest DM, M., Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol, 2009 Mar; 27(3): 158-167.[WoS][Crossref][PubMed]
  • Doral MN, Alam M, Bozkurt M, Turhan E, Atay OA, Dönmez G, Maffulli N. Functional anatomy of the Achilles tendon. Knee Surg Sports Traumatol Arthrosc, 2010 May; 18(5): 638-643.[WoS][PubMed][Crossref]
  • Edwards SG, Calandruccio JH. Autologous blood injections for refractory lateral epicondylitis. J Hand Surg Am, 2003; 28(2): 272-278.[PubMed][Crossref]
  • Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P, Kelberine F, Kon E, Maffulli N, Matheson G, Mei-Dan O, Menetrey J, Philippon M, Randelli P, Schamasch P, Schwellnus M, Vernec A, Verrall G. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med, 2010 Dec; 44(15): 1072-81.[WoS][Crossref][PubMed]
  • Fahlström M, Lorentzon R, Alfredson H. Painful conditions in the Achilles tendon region: a common problem in middle-aged competitive badminton players. Knee Surg Sports Traumatol Arthrosc, 2002 Jan; 10(1): 57-60.[PubMed][Crossref]
  • Filardo G, Presti ML, Kon E, Marcacci M. Nonoperative biological traetment approach for partial Achilles tendon lesion. Orthopedics, 2010 Feb; 33(2): 120-3.[Crossref]
  • Franchini M, Dupplicato P, Ferro I, De Gironcoli M, Aldegheri L. Efficacy of platelet gel in reconstructive bone surgery. Orthopedics, 2005 Feb; 28(2): 161-3.[PubMed]
  • Giddings VL. Beaupre GS, Whalen RT, Carter DR. Calcaneal loading during walking and running. Medicine and science in sports and exercise. Sports Injury, 2000; 32(3): 627-34.
  • Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg, 2009 Oct; 17(10): 602-8.[PubMed]
  • Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sport Med, 2009 Jun; 37(6): 1135-42.[WoS][Crossref]
  • Ip WY, Gogolewski S. Clinical Application of Resorbable Polymers in Guided Bone Regeneration. Macromol. Symp., 2007; 253: 139-146.[Crossref]
  • Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports, 1997 Apr; 7(2): 107-12.[PubMed]
  • Kawasumi M, Kitoh H, Siwicka KA, Ishiquro N. The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br, 2008 Jul; 90(7): 966-72.[Crossref][PubMed][WoS]
  • Khan KM, Forster BB, Robinson J, Cheong Y, Louis L, Maclean L, Taunton JE. Are ultrasound and magnetic resonance imaging of value in assessment of Achilles tendon disorders? A two year prospective study. Br J Sports Med, 2003 Apr; 37(2): 149-53.[PubMed][Crossref]
  • Kjaer M, Langberg H, Skovgaard D, Olesen J, Bülow J, Kroqsqaard M, Boushel R. In vivo studies of peritendinous tissue in exercise. Scand J Med Sci Sports, 2000 Dec; 10(6): 326-31.[Crossref][PubMed]
  • Kon E, Buda R, Filardo G. Platelet rich plasma: intra-articular knee iniection produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc, 2010; 18: 472-479.[Crossref][WoS]
  • Kujala UM, Sarna S, Kaprio J. Cumulative incidence of Achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med, 2005 May; 15(3): 133-5.[Crossref][PubMed]
  • Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med, 2010 Mar; 83(1): 1-9.[PubMed]
  • Langberg H, Skovqaard D, Karamouzis M, Bülow J, Kjaer M. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol, 1999 Mar; 15;515(Pt 3): 919-27.
  • Lopez-Plandolit S, Morales MC, Freire V, Etxebarria J, Duran JA. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea, 2010 Aug; 29(8): 843-8.[WoS][Crossref]
  • Magra M, Maffulli N. Nonsteroidal antiinflammatory drugs in tendinopathy: friend or foe. Clin J Sport Med, 2006; 16: 1-3.[Crossref][PubMed]
  • Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent, 2001; 10(4): 225-8.[Crossref][PubMed]
  • Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang, 2009 Aug; 97(2): 110-8.[Crossref][WoS][PubMed]
  • Milgrom C, Finestone A, Zin D, Mandel D, Novack V. Cold weather training: a risk factor for Achilles paratendinitis among recruits. Foot Ankle Int, 2003 May; 24(5): 398-401.[PubMed]
  • Mohr M, Krustrup P, Bangsbo J. Fatique in soccer: a brief review. J Sports Sci, 2005 Jun; 23(6): 593-9.[Crossref]
  • Owens B, Mountcastle S, White D. Racial differences in tendon rupture incidence. Int J Sports Med, 2007 Jul; 28(7): 617-20.[PubMed][WoS][Crossref]
  • Peerbooms JC. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double blind randomized controlled trial. Platelet-rich plasma versus corticosteroid injection with 1 year follow-up. Amer J Sp Med, 2010; 38(2): 255-262.[Crossref]
  • Peers KH, Brys PP, Lysens RJ. Correlation between power Doppler ultrasonography and clinical severity in Achilles tendinopathy. Int Orthop, 2003; 27(3): 180-3.[PubMed]
  • Pufe T, Petersen WJ, Mentlein R, Tillman BN. The role of vasculature and angiogenesis for pathogenesis of degenerative tendons disease. Scand J Med Sci Sports, 2005 Aug; 15(4): 211-22.[Crossref][PubMed]
  • Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc, 2003 Oct; 35(10): 1648-52.[Crossref]
  • Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J. Bone Joint Surg. Am, 2005 Jan; 87(1): 187-202.[Crossref]
  • Shen YX, Fan ZH, Zhao JG, Zhang P. The application of platelet-rich plasma may be a novel treatment for central nervous system diseases. Med Hypotheses, 2009 Dec; 73(6): 1038-40.[PubMed][Crossref]
  • Silva A, Sampaio R. Anatomic ACL reconstruction: does the platelet-rich plasma accelerate tendon healing. Knee Surg Sports Traumatol Arthrosc, 2009 Jun; 17(6): 676-82.[PubMed][Crossref][WoS]
  • van Sterkenburg MN, de Jonge MC, Sierevelt IN, van Dijk CN. Less promising results with sclerosing ethoxysclerol injections for midportion achilles tendinopathy: a retrospective study. Am J Sports Med, 2010 Nov; 38(11): 2226-32.[Crossref][WoS]
  • Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop, 2006 Oct; 77(5): 806-12.[PubMed]
  • de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA, 2010 Jan; 13;303(2): 144-9.
  • World Anti-Doping Agency Medical Information to Support the Decisions of TUECs Platelet Rich Plasma (PRP). WADA, 2010; The 2010 prohibited list (International Standard).
  • Wright-Carpenter T, Klein P, Schäferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med, 2004 Nov; 25(8): 589-594.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_v10078-011-0076-z
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.